Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Parx Materials N.V. (MLPRX.PA)
Rotterdam, NL
Operating globally, Parx Materials N.V. specializes in the development and distribution of plastics imbued with antibacterial and antimicrobial properties. These advanced materials are applied across diverse industries, such as food contact and packaging, medical devices and implants, textiles, as well as pipes and drainage systems. They also serve in anti-fouling and hygiene applications, effectively deterring mold growth, material degradation, and biofilm formation. The company employs its exclusive, patented "Saniconcentrate" technology. Established in 2012, the company was formerly known as Parx Plastics N.V., changing its name to Parx Materials N.V. in January 2020. Its main office is located in Rotterdam, the Netherlands.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +17.78% | -18.46% | -29.33% | -22.91% | +135.56% | +135.56% | +166.67% | +6.00% | -74.30% | -88.12% | -88.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%-92.0%
-
EPS growth Chemicals - Specialty: +13.2%-279.5%
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-1,080.8%
-
EBIT margin Chemicals - Specialty: +8.8%-1,378.1%
-
ROIC Chemicals - Specialty: +5.6%-7.4%
-
Share dilution Chemicals - Specialty: +0.1%+13.6%
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-1.19×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael van der Jagt | Founder, Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MLPRX.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
